gentamicin c1 has been researched along with amphotericin b in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abbas, SY; Ammar, YA; El Shehry, MF; Fayed, EA; Ghorab, MM; Shedid, SA | 1 |
| Badavath, VN; Gangireddy, MR; Gundla, R; Maddipati, VC; Mandha, SR; Mantipally, M | 1 |
| AbdelAziz, NA; Bondock, S; Fayad, W; Ibrahim, AB; Ibrahim, TM; Nasr, T; Sakr, TM | 1 |
3 other study(ies) available for gentamicin c1 and amphotericin b
| Article | Year |
|---|---|
Quinoline derivatives bearing pyrazole moiety: Synthesis and biological evaluation as possible antibacterial and antifungal agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Chemistry Techniques, Synthetic; Drug Synergism; Fungi; Microbial Sensitivity Tests; Pyrazoles; Quinolines; Structure-Activity Relationship | 2018 |
Rational design, molecular docking and synthesis of novel homopiperazine linked imidazo[1,2-a]pyrimidine derivatives as potent cytotoxic and antimicrobial agents.
Topics: A549 Cells; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; HeLa Cells; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Piperazine; Pyrimidines; Structure-Activity Relationship | 2019 |
New acrylamide-sulfisoxazole conjugates as dihydropteroate synthase inhibitors.
Topics: Acrylamide; Anti-Bacterial Agents; Cells, Cultured; Dihydropteroate Synthase; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship; Sulfisoxazole | 2020 |